Research News and Research

RSS

Zevalin highly effective in first-line treatment of low-grade follicular lymphoma

Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).

6 Dec 2004

New drug can successfully treat patients who have become resistant to Gleevec

A team of prominent researchers led by Charles Sawyers, M.D. and Moshe Talpaz, M.D., presented compelling clinical findings today showing that a new drug, BMS-354825, can successfully treat patients who have become resistant to Gleevec (the frontline therapy for chronic myelogenous leukemia, CML).

5 Dec 2004

Genetic mutations and cellular modifications may provide clues to the associations between slight genetic abnormalities and often fatal diseases

Modern research is delving deep into the human genome to find the answers to medical mysteries and, hopefully, cures for the most deadly diseases. According to four new studies presented during the 46th Annual Meeting of the American Society of Hematology

5 Dec 2004

Researchers step closer to cure for common childhood cancer

Acute lymphoblastic leukemia (ALL) is a malignant disease caused by the abnormal growth and development of white blood cells (WBC) in the bone marrow and blood. ALL is the most common cancer occurring in children with an annual rate of approximately 30 to 40 new cases per million.

5 Dec 2004

Genetic target found for pediatric leukemia

A molecular target newly discovered by scientists at two prestigious research institutes may pave the way for new treatments that could combat an aggressive form of leukemia, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

5 Dec 2004

Genasense shown to enhance the anti-lymphoma activity of Velcade and Rituxan

Genta Incorporated announced that two new studies have shown that Genasense (oblimersen sodium) Injection, the Company's lead anticancer drug, showed synergistic activity with both bortezomib (Velcade; Millennium Pharmaceuticals, Inc.) and rituximab (Rituxan; Genentech, Idec) in experimental models of B-cell non-Hodgkin's lymphoma (NHL).

5 Dec 2004

As mobile phone use rises, possibility of unseen biological impact is quietly troubling

Cell biologists are of two minds about the possible biological effects of mobile phone radiation. In the mid-1990s, studies describing possible pathological effects on tissues bombarded with low-level radio frequencies (RF) were first featured in the popular press and then discredited by scientists.

4 Dec 2004

A gallery of highly-specific, gene and protein “mug shots” of cancer types would be a powerful for oncologists

Doctors would like to diagnose malignancies rapidly by matching them with highly-specific genetic “mug shots” based on the presence of characteristic mRNAs or proteins. This kind of specificity would facilitate screening and early detection, and would potentially allow targeted treatments specific to each type of cancer

4 Dec 2004

Implications of twin, triplet and quadruplet pregnancies on mothers

More women giving birth in their later years has given rise to fertility treatments which has in turn led to what can be described as an explosion in twin, triplets and quadruplet pregnancies.

4 Dec 2004

Herpes virus offers new hope in search for cure for cancer

In laboratory studies at Cincinnati Children's Hospital Medical Center, researchers have successfully treated the most common malignant abdominal tumor of childhood: neuroblastoma tumors.

4 Dec 2004

Botox may reduce the incidence of keloids, improving the appearance of scars

Can a modern-day drug cure an age-old healing disorder that causes more harm than the actual injury?

4 Dec 2004

Research raises question on shark cartilage use as an anti-cancer treatment

The rising popularity of shark cartilage extract as an anti-cancer treatment is a triumph of marketing and pseudoscience over reason, with a tragic fallout for both sharks and humans, according to a Johns Hopkins biologist writing in the Dec. 1 issue of Cancer Research.

4 Dec 2004

New noninvasive technique allows for early detection of chemotherapy treatment response

Scientists at the Arizona Cancer Center have developed an approach that will allow them to detect if cancer patients are responding within days after they start a new chemotherapy regimen.

4 Dec 2004

Study shows gender differences with tatoos and piercing among college students

For college students anxious to rebel against their parents’ fashion sensibilities, getting a tattoo or piercing may be the modern-day equivalent of the 1960s-era fascination with long hair and love beads.

4 Dec 2004

Does quitting smoking really make you gain weight?

If your New Year's resolution is to quit smoking, conventional wisdom says you'll probably put on five or 10 pounds.

4 Dec 2004

Good oil in walnuts helps diabetes patients

People developing Type 2 Diabetes know they need more than an apple a day to keep the doctor away. But a handful of walnuts might help.

4 Dec 2004

Scene-of-the-crime DNA analysis is moving a step closer

Currently DNA analysis is both time-consuming and expensive, but researchers at the Polymer Electronics Research Centre (PERC), within the Faculty of Science and the Faculty of Medical and Health Sciences, hope to change that by inventing a system that provides direct, real-time detection of DNA.

4 Dec 2004

Study will help cancer survivors treated with radical hysterectomy regain their sexual health

When Linda Mercer underwent a radical hysterectomy to treat her cancer, she found herself and her husband struggling to regain a satisfying sex life.

4 Dec 2004

Fossil record of the human immune system reveals antibodies that block cancer metastasis

A team of researchers at The Scripps Research Institute has reconstructed the "fossil record" of the immune systems of a group of human cancer patients to investigate if they had ever produced antibodies against their disease.

4 Dec 2004

Methylphenidate improves attention, behavior of children surviving acute lymphoblastic leukemia, brain tumors

Children who suffer from behavioral and learning problems after their central nervous systems have been exposed to chemotherapy or radiation appear to benefit from treatment with methylphenidate (MPH), the drug commonly known by the brand name Ritalin®.

4 Dec 2004

Research News and Research

Zevalin highly effective in first-line treatment of low-grade follicular lymphoma

New drug can successfully treat patients who have become resistant to Gleevec

Genetic mutations and cellular modifications may provide clues to the associations between slight genetic abnormalities and often fatal diseases

Researchers step closer to cure for common childhood cancer

Genetic target found for pediatric leukemia

Genasense shown to enhance the anti-lymphoma activity of Velcade and Rituxan

As mobile phone use rises, possibility of unseen biological impact is quietly troubling

A gallery of highly-specific, gene and protein “mug shots” of cancer types would be a powerful for oncologists

Implications of twin, triplet and quadruplet pregnancies on mothers

Herpes virus offers new hope in search for cure for cancer

Botox may reduce the incidence of keloids, improving the appearance of scars

Research raises question on shark cartilage use as an anti-cancer treatment

New noninvasive technique allows for early detection of chemotherapy treatment response

Study shows gender differences with tatoos and piercing among college students

Does quitting smoking really make you gain weight?

Good oil in walnuts helps diabetes patients

Scene-of-the-crime DNA analysis is moving a step closer

Study will help cancer survivors treated with radical hysterectomy regain their sexual health

Fossil record of the human immune system reveals antibodies that block cancer metastasis

Methylphenidate improves attention, behavior of children surviving acute lymphoblastic leukemia, brain tumors

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®